Supply of Amlodipine Besylate 5 mg Tablets (90-count bottles)

The contract entails the manufacture and delivery of 5 mg amlodipine besylate tablets in 90-count bottles, with strict adherence to regulatory standards and full serialization to ensure traceability throughout the supply chain. The product must be fully compatible with automated dispensing systems used in institutional and healthcare settings, requiring precise packaging, labeling, and physical dimensions to support seamless integration. Compliance with all applicable pharmaceutical regulations, including those governing Good Manufacturing Practices, is mandatory, and the supplier is expected to maintain documentation proving quality control, batch consistency, and regulatory approvals. Delivery is obligated to meet the needs of the Department of Defense through DLA Troop Support, with the contract classified as a subcontract under NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on July 13, 2026, with responses required by August 13, 2026, at 7:00 p.m. Eastern Time. While specific performance locations and point of contact details are not provided, the work must be executed to fulfill defense medical supply chain requirements, ensuring uninterrupted availability of this critical cardiovascular medication for military and veteran healthcare systems.